GVCCX
Price
$6.98
Change
-$0.03 (-0.43%)
Updated
Sep 20 closing price
VIMSX
Price
$71.38
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

GVCCX vs VIMSX

Header iconGVCCX vs VIMSX Comparison
Open Charts GVCCX vs VIMSXBanner chart's image
Gabelli Value 25 C
Price$6.98
Change-$0.03 (-0.43%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$71.38
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GVCCX vs VIMSX Comparison Chart
Loading...
VS
GVCCX vs. VIMSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVCCX is a Buy and VIMSX is a Buy.

FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 172B vs. GVCCX (219M). VIMSX pays higher dividends than GVCCX: VIMSX (1.38) vs GVCCX (0.00). GVCCX was incepted earlier than VIMSX: GVCCX (25 years) vs VIMSX (26 years). VIMSX is a more actively managed with annual turnover of: 13.00 vs. GVCCX (6.00). GVCCX has a lower initial minimum investment than VIMSX: GVCCX (1000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 25.11 vs. GVCCX (6.24). VIMSX return over 5 years is better than : 56.75 vs. GVCCX (-35.79).
GVCCXVIMSXGVCCX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years26 years-
Gain YTD11.14612.55789%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets219M172B0%
Annual Yield % from dividends0.001.38-
Returns for 1 year6.2425.1125%
Returns for 3 years-33.669.82-343%
Returns for 5 years-35.7956.75-63%
Returns for 10 years-58.61128.21-46%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMFG12.870.16
+1.26%
Sumitomo Mitsui Financial Group
KTCC5.240.02
+0.38%
Key Tronic Corp
DDS368.160.65
+0.18%
Dillards
JSPR23.88-0.03
-0.13%
Jasper Therapeutics
AHCO11.25-0.05
-0.44%
AdaptHealth Corp